U.S. FDA Withdraws Proposed Testing Rule for Talc-Containing Cosmetics
End of last year, the U.S. Food and Drug Administration (FDA) issued an unpublished notice titled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal,” formally withdrawing its previously proposed rule on this topic. The withdrawal took effect upon the issuance of the notice. Under the now-withdrawn proposal, FDA had considered establishing specific […]
FDA Proposes Adding Bemotrizinol to the List of Permitted Sunscreen Active Ingredients
The U.S. Food and Drug Administration (FDA) has issued a proposed order that would add bemotrizinol to the list of permitted sunscreen active ingredients. According to the FDA: – bemotrizinol provides broad-spectrum UV protection and demonstrates low systemic absorption. – Bemotrizinol has a low irritation potential– if the proposed order is finalized, it would be […]
USA – FDA’s RFI on Future Gluten Labelling Regulations
Back in January, the US Food and Drug Administration (FDA) issued a Request for Information (RFI) to gather input on potential gaps in the current gluten labelling framework. Currently, products labelled “gluten-free” must contain less than 20 ppm of gluten. However, manufacturers are not required to disclose all gluten-containing grains […]
USA – Labels Amendments and Amazon’s New Certification Requirements
DSHEA label disclaimer On December 11th, the U.S. Food and Drug Administration (FDA) released a letter to the Dietary Supplement industry confirming that it is considering amending 21 CFR 101.93(d) in response to several requests to change the current labelling regulation. As mandated by the Dietary Supplement Health and Education Act […]
USA – FDA Launches Dashboard for Cosmetic Product Adverse Events
On September 12, 2025, the U.S. Food and Drug Administration (FDA) announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products — a new tool designed to improve transparency and give the public real-time access to adverse event data related to cosmetics. This initiative is part of the FDA’s […]
USA – NMN exclusion | FDA’s Proposed Changes to GRAS
NMN is (again) Legal in Dietary Supplements At the end of last month, after nearly three years of discussions, the U.S. Food and Drug Administration (FDA) announced its position that nicotinamide mononucleotide (NMN) is not excluded from the legal definition of a dietary supplement. Previously, the FDA had taken […]
USA: Tariff-Exempt Dietary Ingredients | FDA Opinion on New Dietary Ingredients | FDA & the Potential Halt of GRAS Process | Restriction on the Sale of Dietary Supplements to Children and Adolescents
Dietary Ingredients Exempt from Global and Reciprocal Tariffs Although some Global or Reciprocal Tariffs may be suspended for 90 days, certain Dietary Supplement ingredients have been declared exempt. According to Annex II of the executive order that implemented these tariffs, the following dietary ingredients are exempt: Vitamin A Vitamins B1, B2, B5, […]
